Table of Contents Timeline Constraints from the Source Trials Months 03 Retatrutide Alone, Titration Phase Months 37 Cagrilintide Layered, Stack Titration Months 712 Stack at Maintenance Plateau-Breaking When Cagrilintide Earns Its Layer What Affects Stack Results Body Composition Through the Timeline When Results Plateau Related Reading References Timeline Constraints from the Source Trials Anchoring point: weight loss continues to progress through 68 weeks in both retatrutide Phase 3 and cagrilintide+semaglutide Phase 3
Diao, Sun, Ma, Li, & Wang, 2018)
"Let's say you take too much and you're feeling really nauseous, or you are throwing up," Thiara said
Matsuo K, Cheng A, Yabuki Y, Takahata I, Miyachi H, Fukunaga K (2019) Inhibition of MPTP-induced -synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice